iridium radioisotopes has been researched along with Carcinoma, Endometrioid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caretto, M; Coccia, N; Fuentes, T; Gadducci, A; Laliscia, C; Mattioni, R; Morganti, R; Paiar, F; Perrone, F; Pistolesi, S; Puccini, P | 1 |
| Delaloye, JF; Frankendal, B; Kuhelj, D; Kuhelj, J; Mäenpää, J; Nordström, B; Okkan, S; Sorbe, B | 1 |
1 trial(s) available for iridium radioisotopes and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Endometrioid; Cesium Radioisotopes; Cobalt Radioisotopes; Dose Fractionation, Radiation; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Rate; Treatment Outcome | 2009 |
1 other study(ies) available for iridium radioisotopes and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy.
Topics: Brachytherapy; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Hysterectomy; Iridium Radioisotopes; Lymph Node Excision; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tumor Suppressor Protein p53 | 2023 |